Perfil
Alistair Duncan is the founder of Chromos Molecular Systems, Inc. (founded in 1998) and.
viDA Therapeutics, Inc. (founded in 2008).
He holds the title of President & Chief Executive Officer at Chromos Molecular Systems, Inc. in 2008 and President, Chief Executive Officer & Director at viDA Therapeutics, Inc. He is currently a Director at Metro Vancouver Properties Corp.
Mr. Duncan previously worked as a Director at MIGENIX, Inc. from 2004 to 2010, Director at Global Gaming Technologies Corp.
from 2010 to 2012, and Director at BC Technology Industry Association and Michael Smith Foundation for Health Research.
He also held the position of Principal at Ernst & Young LLP, Chief Financial Officer at Agrisoma Biosciences, Inc., and was a Member of The Institute of Chartered Accountants of British Columbia.
Mr. Duncan completed his undergraduate degree at the University of British Columbia.
Cargos activos de Alistair Duncan
| Empresas | Cargo | Inicio |
|---|---|---|
Metro Vancouver Properties Corp.
 Metro Vancouver Properties Corp. Real Estate DevelopmentFinance Metro Vancouver Properties Corp. provides real estate brokerage services. The company is headquartered in Vancouver, Canada. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Alistair Duncan.
| Empresas | Cargo | Fin |
|---|---|---|
| The Institute of Chartered Accountants of British Columbia | Corporate Officer/Principal | 22/10/2012 |
MIGENIX, Inc.
 MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Director/Miembro de la Junta | 24/03/2010 |
Chromos Molecular Systems, Inc.
 Chromos Molecular Systems, Inc. BiotechnologyHealth Technology Chromos is a cellular engineering and therapeutics company creating value through engineering production quality cell lines for the manufacture of biopharmaceuticals, and developing innovative therapies for infectious diseases, cancer and genetic disorders. Chromos is achieving these objectives with its ACE System (Artificial Chromosome Expression) and REM (Rapid Expansion Method) technologies. In the near term, Chromos will focus on continued commercialization of the ACE System for engineering cell lines. To date Chromos has entered into corporate partnerships related to cell line engineering with partners including Pfizer Inc., Centocor, Inc. and Cambridge Antibody Technology | Fundador | 16/04/2008 |
Agrisoma Biosciences, Inc.
 Agrisoma Biosciences, Inc. Chemicals: SpecialtyProcess Industries Agrisoma Biosciences, Inc. provides crop technology for biofuel and renewable energy solutions. Its crop improvement technologies include proprietary breeding, proprietary tissue culture and haploidy, molecular markers and genetic mapping and advanced crop improvement technologies. The company was founded by Steven Fabijanski and Tom Mamic in 2001 and is headquartered in Gatineau, Canada. | Director Financiero/CFO | - |
| GLOBAL GAMING TECHNOLOGIES CORP. | Director/Miembro de la Junta | - |
Formación de Alistair Duncan.
| University of British Columbia | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GLOBAL GAMING TECHNOLOGIES CORP. | Finance |
| Empresas privadas | 8 |
|---|---|
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Health Technology |
Michael Smith Foundation for Health Research
 Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012. | Miscellaneous |
| BC Technology Industry Association | |
Chromos Molecular Systems, Inc.
Chromos Molecular Systems, Inc. BiotechnologyHealth Technology Chromos is a cellular engineering and therapeutics company creating value through engineering production quality cell lines for the manufacture of biopharmaceuticals, and developing innovative therapies for infectious diseases, cancer and genetic disorders. Chromos is achieving these objectives with its ACE System (Artificial Chromosome Expression) and REM (Rapid Expansion Method) technologies. In the near term, Chromos will focus on continued commercialization of the ACE System for engineering cell lines. To date Chromos has entered into corporate partnerships related to cell line engineering with partners including Pfizer Inc., Centocor, Inc. and Cambridge Antibody Technology | Health Technology |
Agrisoma Biosciences, Inc.
Agrisoma Biosciences, Inc. Chemicals: SpecialtyProcess Industries Agrisoma Biosciences, Inc. provides crop technology for biofuel and renewable energy solutions. Its crop improvement technologies include proprietary breeding, proprietary tissue culture and haploidy, molecular markers and genetic mapping and advanced crop improvement technologies. The company was founded by Steven Fabijanski and Tom Mamic in 2001 and is headquartered in Gatineau, Canada. | Process Industries |
Metro Vancouver Properties Corp.
Metro Vancouver Properties Corp. Real Estate DevelopmentFinance Metro Vancouver Properties Corp. provides real estate brokerage services. The company is headquartered in Vancouver, Canada. | Finance |
| The Institute of Chartered Accountants of British Columbia | Commercial Services |
- Bolsa de valores
- Insiders
- Alistair Duncan